article thumbnail

The Challenge of Growing Pharma Sales

Quantified

With only 50 novel drug approvals by the FDA across the entire industry in a typical year, the opportunity to build the institutional knowledge and refine launch marketing and sales fundamentals is an order of magnitude lower than, say, in consumer goods where there might be upwards of 4 brand initiatives a year.

Sales 52
article thumbnail

Unveiling the Roadmap: Navigating Medical Sales Rep Requirements

Rep-Lite

This also requires medical sales representatives to be familiar with clinical data based on research and FDA regulations to ensure compliance. Vertical Growth Paths Medical sales offer sales growth and advancement through specialization, territory expansion, key account management, strategic partnerships, or product management.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Selling Effectively In Medical Sales With John Crowder

Evolve Your Success

You have to be able to talk about your product, especially in our field because it’s so governed by the FDA. Most people come into the sales process with the belief system that selling is talking about my product. That is true. It’s litigious. We’re restricted. There’s so much oversight.

article thumbnail

Quality first: How pharma can meet injectables demand while staying compliant

Pharmaceutical Technology

According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. The demand for injectable drugs is rising. This was higher than the number of approvals in 2019 and 2020.

Pharma 52